Literature DB >> 29119223

[Acute myocardial infarction in patients with ST-segment elevation myocardial infarction : ESC guidelines 2017].

H Thiele1, S Desch2,3, S de Waha3,4.   

Abstract

This article gives an update on the management of acute ST-segment elevation myocardial infarction (STEMI) according to the recently released European Society of Cardiology guidelines 2017 and the modifications are compared to the previous STEMI guidelines from 2012. Primary percutaneous coronary intervention (PCI) remains the preferred reperfusion strategy. New guideline recommendations relate to the access site with a clear preference for the radial artery, use of drug-eluting stents over bare metal stents, complete revascularization during the index hospitalization, and avoidance of routine thrombus aspiration. For periprocedural anticoagulation during PCI, bivalirudin has been downgraded. Oxygen treatment should be administered only if oxygen saturation is <90%. In cardiogenic shock, intra-aortic balloon pumps should no longer be used. New recommendations are in place with respect to the duration of dual antiplatelet therapy for patients without bleeding events during the first 12 months. Newly introduced sections cover myocardial infarction with no relevant stenosis of the coronary arteries (MINOCA), the introduction of new indicators for quality of care for myocardial infarction networks and new definitions for the time to reperfusion.

Entities:  

Keywords:  Acute coronary syndrome; Coronary artery disease; Guideline; Myocardial infarction; Reperfusion

Mesh:

Year:  2017        PMID: 29119223     DOI: 10.1007/s00059-017-4641-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  43 in total

1.  Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.

Authors:  Vincent Roolvink; Borja Ibáñez; Jan Paul Ottervanger; Gonzalo Pizarro; Niels van Royen; Alonso Mateos; Jan-Henk E Dambrink; Noemi Escalera; Erik Lipsic; Agustín Albarran; Antonio Fernández-Ortiz; Francisco Fernández-Avilés; Javier Goicolea; Javier Botas; Wouter Remkes; Victoria Hernandez-Jaras; Elvin Kedhi; José L Zamorano; Felipe Navarro; Fernando Alfonso; Alberto García-Lledó; Joaquin Alonso; Maarten van Leeuwen; Robin Nijveldt; Sonja Postma; Evelien Kolkman; Marcel Gosselink; Bart de Smet; Saman Rasoul; Jan J Piek; Valentin Fuster; Arnoud W J van 't Hof
Journal:  J Am Coll Cardiol       Date:  2016-04-03       Impact factor: 24.094

2.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

Authors:  Stefan Agewall; John F Beltrame; Harmony R Reynolds; Alexander Niessner; Giuseppe Rosano; Alida L P Caforio; Raffaele De Caterina; Marco Zimarino; Marco Roffi; Keld Kjeldsen; Dan Atar; Juan C Kaski; Udo Sechtem; Per Tornvall
Journal:  Eur Heart J       Date:  2017-01-14       Impact factor: 29.983

3.  Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

Authors:  Steen D Kristensen; Kristina G Laut; Jean Fajadet; Zuzana Kaifoszova; Petr Kala; Carlo Di Mario; William Wijns; Peter Clemmensen; Vaja Agladze; Loizos Antoniades; Khalid F Alhabib; Menko-Jan De Boer; Marc J Claeys; Dan Deleanu; Dariusz Dudek; Andrejs Erglis; Martine Gilard; Omer Goktekin; Giulio Guagliumi; Thorarinn Gudnason; Kim Wadt Hansen; Kurt Huber; Stefan James; Tomáš Janota; Siobhan Jennings; Olli Kajander; John Kanakakis; Kiril K Karamfiloff; Sasko Kedev; Ran Kornowski; Peter F Ludman; Béla Merkely; Davor Milicic; Ruslan Najafov; Francesca A Nicolini; Marko Noč; Miodrag Ostojic; Hélder Pereira; Dragana Radovanovic; Manel Sabaté; Mohamed Sobhy; Maxim Sokolov; Martin Studencan; Ibrahim Terzic; Steffen Wahler; Petr Widimsky
Journal:  Eur Heart J       Date:  2014-01-12       Impact factor: 29.983

Review 4.  Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries.

Authors:  Sivabaskari Pasupathy; Tracy Air; Rachel P Dreyer; Rosanna Tavella; John F Beltrame
Journal:  Circulation       Date:  2015-01-13       Impact factor: 29.690

5.  Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.

Authors:  Kaare H Bønaa; Jan Mannsverk; Rune Wiseth; Lars Aaberge; Yngvar Myreng; Ottar Nygård; Dennis W Nilsen; Nils-Einar Kløw; Michael Uchto; Thor Trovik; Bjørn Bendz; Sindre Stavnes; Reidar Bjørnerheim; Alf-Inge Larsen; Morten Slette; Terje Steigen; Ole J Jakobsen; Øyvind Bleie; Eigil Fossum; Tove A Hanssen; Øystein Dahl-Eriksen; Inger Njølstad; Knut Rasmussen; Tom Wilsgaard; Jan E Nordrehaug
Journal:  N Engl J Med       Date:  2016-08-29       Impact factor: 91.245

6.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Authors:  Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Journal:  Lancet       Date:  2011-04-04       Impact factor: 79.321

7.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

8.  Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.

Authors:  Nikolaus Sarafoff; Amadea Martischnig; Jill Wealer; Katharina Mayer; Julinda Mehilli; Dirk Sibbing; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

Authors:  Manel Sabaté; Salvatore Brugaletta; Angel Cequier; Andrés Iñiguez; Antonio Serra; Pilar Jiménez-Quevedo; Vicente Mainar; Gianluca Campo; Maurizio Tespili; Peter den Heijer; Armando Bethencourt; Nicolás Vazquez; Gerrit Anne van Es; Bianca Backx; Marco Valgimigli; Patrick W Serruys
Journal:  Lancet       Date:  2015-10-29       Impact factor: 79.321

10.  Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Authors:  Anthony H Gershlick; Jamal Nasir Khan; Damian J Kelly; John P Greenwood; Thiagarajah Sasikaran; Nick Curzen; Daniel J Blackman; Miles Dalby; Kathryn L Fairbrother; Winston Banya; Duolao Wang; Marcus Flather; Simon L Hetherington; Andrew D Kelion; Suneel Talwar; Mark Gunning; Roger Hall; Howard Swanton; Gerry P McCann
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

View more
  12 in total

1.  Risk Factors of Ischemia Reperfusion Injury After PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction and its Influence on Prognosis.

Authors:  Li Zhang; Lingqing Wang; Luyuan Tao; Changgong Chen; Shijia Ren; Youyou Zhang
Journal:  Front Surg       Date:  2022-06-07

2.  Relationship between Admission Electrolyte Level and Short-term Prognosis of Patients with Acute ST-segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Yaping Ren; Zhijie Yue; Xuewen Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

3.  Distal radial artery access in the anatomical snuffbox for coronary angiography and intervention: A single center experience.

Authors:  Weiwei Yu; Pengfei Hu; Shen Wang; Liping Yao; Hao Wang; Liping Dou; Ming Lu; Gang Bo; Xixia Yu; Jingwen Chen; Chao Chen; Ying Luo; Ming Yang; Zhuqin Dong; Shuwei Huang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

4.  Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.

Authors:  Xin Chu; Ruzhu Wang; Guixian Song; Xiaohan Jiang
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

5.  Distal radial approach between theory and clinical practice.. Time to go distal!

Authors:  Mohamed I Sanhoury; Mohamed A Sobhy; Mohamed A Saddaka; Mohamed A Nassar; Mostafa N Elwany
Journal:  Egypt Heart J       Date:  2022-02-05

6.  Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A propensity score-matched retrospective study.

Authors:  Yu-Long Xue; Yue-Teng Ma; Yu-Ping Gao; Sheng-Xiao Zhang; Qin-Yi Su; Yu-Feng Li; Lei Zhang; Peng-Fei Ding; Xue-Wen Li
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

7.  The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels.

Authors:  Lijun Zhu; Jiamin Zheng; Beibei Gao; Xiangbo Jin; Ying He; Liang Zhou; Jinyu Huang
Journal:  BMC Cardiovasc Disord       Date:  2022-04-15       Impact factor: 2.174

8.  Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention.

Authors:  Shu-Min Chang; Yan-Tan Yu; Bo Luan; Ai-Jie Hou; Yong Wang
Journal:  J Interv Cardiol       Date:  2022-04-15       Impact factor: 1.776

9.  Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Xiuying Tang; Jie Gong
Journal:  Cardiol Res Pract       Date:  2022-07-02       Impact factor: 1.990

10.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.